You allocate 1⁄4 to new interventions (presumably higher-risk/higher-reward) - do you agree with OpenPhil’s post you link to and are you going to fund those preferably given the funding shortfall?
Do you agree OpenPhil that Givewell’s interventions have ~the same CBA during economic crises? For instance, AMF is now expanding to Nigeria, where GDP/capita gone down to 2008 levels and generally Malaria deaths are up ~10% due to Covid. Does this increase the CBA of your core interventions? Relatedly: $150m seems quite a large reduction—OpenPhil considered using mission hedging at the last year’s EAG—have you considered this for your assets?
You allocate 1⁄4 to new interventions (presumably higher-risk/higher-reward) - do you agree with OpenPhil’s post you link to and are you going to fund those preferably given the funding shortfall?
Do you agree OpenPhil that Givewell’s interventions have ~the same CBA during economic crises? For instance, AMF is now expanding to Nigeria, where GDP/capita gone down to 2008 levels and generally Malaria deaths are up ~10% due to Covid. Does this increase the CBA of your core interventions? Relatedly: $150m seems quite a large reduction—OpenPhil considered using mission hedging at the last year’s EAG—have you considered this for your assets?